Toll Free: 1-888-928-9744
Published: Aug, 2014 | Pages:
36 | Publisher: Global Markets Direct
Industry: Pharmaceutical | Report Format: Electronic (PDF)
Argos Therapeutics, Inc. - Product Pipeline Review - 2014 Summary Global Markets Direct's, 'Argos Therapeutics, Inc. - Product Pipeline Review - 2014', provides an overview of the Argos Therapeutics, Inc.'s pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of Argos Therapeutics, Inc.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects. Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease. Scope - The report provides brief overview of Argos Therapeutics, Inc. including business description, key information and facts, and its locations and subsidiaries - The report reviews current pipeline of Argos Therapeutics, Inc.'s human therapeutic division and enlists all their major and minor projects - The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones - Special feature on out-licensed and partnered product portfolio - The report summarizes all the dormant and discontinued pipeline projects - Latest company statement - Latest news and deals relating to the Argos Therapeutics, Inc.'s pipeline products Reasons to buy - Evaluate Argos Therapeutics, Inc.'s strategic position with total access to detailed information on its product pipeline - Assess the growth potential of Argos Therapeutics, Inc. in its therapy areas of focus - Identify new drug targets and therapeutic classes in the Argos Therapeutics, Inc.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas - Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps - Develop strategic initiatives by understanding the focus areas of Argos Therapeutics, Inc. and exploit collaboration and partnership opportunities - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Plan mergers and acquisitions effectively by identifying the most promising pipeline of Argos Therapeutics, Inc. - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope - Explore the dormant and discontinued projects of Argos Therapeutics, Inc. and identify potential opportunities in those areas - Avoid Intellectual Property Rights related issues
Table of Contents Table of Contents 2 List of Tables 4 List of Figures 4 Argos Therapeutics, Inc. Snapshot 5 Argos Therapeutics, Inc. Overview 5 Key Information 5 Key Facts 5 Argos Therapeutics, Inc. - Research and Development Overview 6 Key Therapeutic Areas 6 Argos Therapeutics, Inc. - Pipeline Review 8 Pipeline Products by Stage of Development 8 Pipeline Products - Monotherapy 9 Argos Therapeutics, Inc. - Pipeline Products Glance 10 Argos Therapeutics, Inc. - Late Stage Pipeline Products 10 Phase III Products/Combination Treatment Modalities 10 Argos Therapeutics, Inc. - Clinical Stage Pipeline Products 11 Phase II Products/Combination Treatment Modalities 11 Phase I Products/Combination Treatment Modalities 12 Argos Therapeutics, Inc. - Early Stage Pipeline Products 13 Preclinical Products/Combination Treatment Modalities 13 Argos Therapeutics, Inc. - Drug Profiles 14 AGS-003 14 Product Description 14 Mechanism of Action 14 R&D Progress 14 AGS-004 17 Product Description 17 Mechanism of Action 17 R&D Progress 17 AGS-009 19 Product Description 19 Mechanism of Action 19 R&D Progress 19 AGS-010 20 Product Description 20 Mechanism of Action 20 R&D Progress 20 Argos Therapeutics, Inc. - Pipeline Analysis 22 Argos Therapeutics, Inc. - Pipeline Products by Target 22 Argos Therapeutics, Inc. - Pipeline Products by Route of Administration 23 Argos Therapeutics, Inc. - Pipeline Products by Molecule Type 24 Argos Therapeutics, Inc. - Pipeline Products by Mechanism of Action 25 Argos Therapeutics, Inc. - Recent Pipeline Updates 26 Argos Therapeutics, Inc. - Dormant Projects 32 Argos Therapeutics, Inc. - Discontinued Pipeline Products 33 Discontinued Pipeline Product Profiles 33 AGS-003 33 AGS-004 33 MB-002 33 Argos Therapeutics, Inc. - Locations And Subsidiaries 34 Head Office 34 Appendix 35 Methodology 35 Coverage 35 Secondary Research 35 Primary Research 35 Expert Panel Validation 35 Contact Us 36 Disclaimer 36
List of Tables Argos Therapeutics, Inc., Key Information 5 Argos Therapeutics, Inc., Key Facts 5 Argos Therapeutics, Inc. - Pipeline by Indication, 2014 7 Argos Therapeutics, Inc. - Pipeline by Stage of Development, 2014 8 Argos Therapeutics, Inc. - Monotherapy Products in Pipeline, 2014 9 Argos Therapeutics, Inc. - Phase III, 2014 10 Argos Therapeutics, Inc. - Phase II, 2014 11 Argos Therapeutics, Inc. - Phase I, 2014 12 Argos Therapeutics, Inc. - Preclinical, 2014 13 Argos Therapeutics, Inc. - Pipeline by Target, 2014 22 Argos Therapeutics, Inc. - Pipeline by Route of Administration, 2014 23 Argos Therapeutics, Inc. - Pipeline by Molecule Type, 2014 24 Argos Therapeutics, Inc. - Pipeline Products by Mechanism of Action, 2014 25 Argos Therapeutics, Inc. - Recent Pipeline Updates, 2014 26 Argos Therapeutics, Inc. - Dormant Developmental Projects,2014 32 Argos Therapeutics, Inc. - Discontinued Pipeline Products, 2014 33
Speak to the report author to design an exclusive study to serve your research needs.
Your personal and confidential information is safe and secure.